Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Medartis Holding Yönetim
Yönetim kriter kontrolleri 3/4
Medartis Holding's CEO'su Christoph Bronnimann, Sep2019 tarihinde atandı, in görev süresi 5.08 yıldır. in toplam yıllık tazminatı CHF 1.87M olup, şirket hissesi ve opsiyonları dahil olmak üzere 26.8% maaş ve 73.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.27% ine doğrudan sahiptir ve bu hisseler CHF 2.12M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 3.5 yıldır.
Anahtar bilgiler
Christoph Bronnimann
İcra Kurulu Başkanı
CHF 1.9m
Toplam tazminat
| CEO maaş yüzdesi | 26.8% |
| CEO görev süresi | 5.1yrs |
| CEO sahipliği | 0.3% |
| Yönetim ortalama görev süresi | 3.8yrs |
| Yönetim Kurulu ortalama görev süresi | 3.5yrs |
Son yönetim güncellemeleri
Recent updates
The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business
Aug 27
Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares
Aug 21When Should You Buy Medartis Holding AG (VTX:MED)?
May 10Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation
Apr 11The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence
Feb 14Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Oct 24Is Medartis Holding (VTX:MED) A Risky Investment?
Oct 03Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 06Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)
Jun 21Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital
Jan 31Why Medartis Holding AG (VTX:MED) Could Be Worth Watching
Oct 30These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat
Sep 07When Should You Buy Medartis Holding AG (VTX:MED)?
Jul 29Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
May 06At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?
Feb 08Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Jan 18We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt
Nov 10Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
Sep 29Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital
Jun 08How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?
Mar 16We're Watching These Trends At Medartis Holding (VTX:MED)
Feb 09
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain
Jan 04What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?
Nov 19CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CHF 4m |
| Mar 31 2024 | n/a | n/a | CHF 2m |
| Dec 31 2023 | CHF 2m | CHF 500k | CHF 619k |
| Sep 30 2023 | n/a | n/a | -CHF 3m |
| Jun 30 2023 | n/a | n/a | -CHF 7m |
| Mar 31 2023 | n/a | n/a | -CHF 6m |
| Dec 31 2022 | CHF 2m | CHF 500k | -CHF 6m |
| Sep 30 2022 | n/a | n/a | -CHF 3m |
| Jun 30 2022 | n/a | n/a | -CHF 241k |
| Mar 31 2022 | n/a | n/a | CHF 3m |
| Dec 31 2021 | CHF 3m | CHF 500k | CHF 7m |
| Sep 30 2021 | n/a | n/a | CHF 9m |
| Jun 30 2021 | n/a | n/a | CHF 12m |
| Mar 31 2021 | n/a | n/a | CHF 6m |
| Dec 31 2020 | CHF 2m | CHF 467k | -CHF 944k |
| Sep 30 2020 | n/a | n/a | -CHF 3m |
| Jun 30 2020 | n/a | n/a | -CHF 4m |
| Mar 31 2020 | n/a | n/a | -CHF 1m |
| Dec 31 2019 | CHF 782k | CHF 168k | CHF 2m |
Tazminat ve Piyasa: Christoph's total compensation ($USD2.21M) is above average for companies of similar size in the Swiss market ($USD1.53M).
Tazminat ve Kazançlar: Christoph's compensation has been consistent with company performance over the past year.
CEO
Christoph Bronnimann (58 yo)
5.1yrs
Görev süresi
CHF 1,866,937
Tazminat
Dr. Christoph Bronnimann is Chief Executive Officer at Medartis AG since September 2019. He has been the Chief Executive Officer and Member of Executive Management Board at Medartis Holding AG since Septem...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Member of Executive Management Board | 5.1yrs | CHF 1.87m | 0.27% CHF 2.1m | |
| Founder & Vice Chairman | 26.8yrs | CHF 291.97k | 41.41% CHF 321.7m | |
| CFO & Member of the Executive Management Board | 3.6yrs | Veri yok | 0.029% CHF 227.1k | |
| VP of EMEA & Member of Executive Management Board | 4.2yrs | Veri yok | 0.053% CHF 415.5k | |
| CTO & Member of the Executive Board | 3.9yrs | Veri yok | 0.017% CHF 132.0k | |
| COO & Member of Management Board | 2.8yrs | Veri yok | 0.0027% CHF 20.8k | |
| Chief Human Resources Officer & Executive Management Board Member | no data | Veri yok | Veri yok | |
| Head of Regulatory Affairs | 3.6yrs | Veri yok | Veri yok |
3.8yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: MED's management team is considered experienced (3.8 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder & Vice Chairman | 26.8yrs | CHF 291.97k | 41.41% CHF 321.7m | |
| Independent Non-Executive Director | 6.8yrs | CHF 188.29k | 0.19% CHF 1.5m | |
| Independent Chairman | 4.5yrs | CHF 568.06k | 0.065% CHF 505.7k | |
| Independent Director | 2.5yrs | CHF 112.76k | 0.0096% CHF 74.9k | |
| Independent Non Executive Director | 14.8yrs | CHF 161.68k | 4.55% CHF 35.3m | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok | |
| Independent Director | 2.5yrs | CHF 171.53k | 0.0072% CHF 56.2k |
3.5yrs
Ortalama Görev Süresi
60.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: MED's board of directors are considered experienced (3.5 years average tenure).